000 | 01130 a2200313 4500 | ||
---|---|---|---|
005 | 20250515154151.0 | ||
264 | 0 | _c20090206 | |
008 | 200902s 0 0 eng d | ||
022 | _a1365-2044 | ||
024 | 7 |
_a10.1111/j.1365-2044.2008.05840_1.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHudson, P C | |
245 | 0 | 0 |
_aRemifentanil for fibre-optic intubation: dose considerations. _h[electronic resource] |
260 |
_bAnaesthesia _cFeb 2009 |
||
300 |
_a221; author reply 221-2 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aConscious Sedation _xmethods |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFiber Optic Technology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypnotics and Sedatives _xadministration & dosage |
650 | 0 | 4 |
_aIntubation, Intratracheal _xmethods |
650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
650 | 0 | 4 | _aRemifentanil |
700 | 1 | _aNorman, A T | |
700 | 1 | _aFreeman, D J | |
773 | 0 |
_tAnaesthesia _gvol. 64 _gno. 2 _gp. 221; author reply 221-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2044.2008.05840_1.x _zAvailable from publisher's website |
999 |
_c18591588 _d18591588 |